Cadonilimab Combined With Anlotinib Followed by Radiotherapy in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma (CAR-RMEC)
Clinical trial NCT06681285 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06681285
- Sponsor
- Hebei Medical University Fourth Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-01
- Primary completion
- 2027-12-31
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.